Clinical Trial Results: Myelodysplastic Syndromes

Home

Results

This database is populated with information on the results of Roche-sponsored clinical trials.

Product Name: NeoRecormon [epoetin beta]
Date of Report: To be Published
Phase: II
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement